Monocyte-endothelial cell interactions in the development of atherosclerosis
- PMID: 19185814
- PMCID: PMC2650852
- DOI: 10.1016/j.tcm.2008.11.004
Monocyte-endothelial cell interactions in the development of atherosclerosis
Abstract
The activation of endothelial cells at atherosclerotic lesion-prone sites in the arterial tree results in the up-regulation of cell adhesion molecules and chemokines, which mediate the recruitment of circulating monocytes. Accumulation of monocytes and monocyte-derived phagocytes in the wall of large arteries leads to chronic inflammation and the development and progression of atherosclerosis. This review discusses the nature of these molecules and the mechanisms involved in the early steps of monocyte recruitment into atherosclerotic lesion sites within the vessel wall.
References
-
- Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med. 2007;13:587–96. - PubMed
-
- Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2−/−-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998;394:894–7. - PubMed
-
- Braunersreuther V, Steffens S, Arnaud C, Pelli G, Burger F, Proudfoot A, et al. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice. Arterioscler Thromb Vasc Biol. 2008;28:1090–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical